Lannett Company Competitors
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|---|
TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.29 | Buy/Sell | $11.59 | 4.36% | 9 | $18.45B |
AUROPHARMA | Aurobindo Pharma | Outperform |
18
|
Rp1.17k | Buy/Sell | Rp1.09k | 1.28% | 20 | Rp653.50B |
HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.78 | Buy/Sell | £28.11 | 47.67% | 9 | £4.42B |
APN | Aspen Pharmacare Holdings | Outperform |
18
|
R229.79 | Buy/Sell | R202.49 | 2.33% | 1 | R102.44B |
RICHTER | Outperform |
18
|
Ft9.29k | Buy/Sell | Ft11.02k | 26.01% | 2 | Ft1.75T | |
KRKG | Krka, d. d. | Buy |
18
|
126.00€ | Buy/Sell | 119.80€ | 13.10% | 0 | 3.88€B |
PRGO | Perrigo Co PLC | Outperform |
16
|
$29.83 | Buy/Sell | $44.75 | 34.09% | 0 | $4.19B |
GLENMARK | Glenmark Pharmaceuticals | Outperform |
18
|
Rp1.02k | Buy/Sell | Rp767.80 | -11.28% | 9 | Rp287.70B |
AMRX | Amneal Pharmaceuticals | Outperform |
16
|
$6.82 | Buy/Sell | $6.13 | 17.30% | 1 | $2.09B |
AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$43.48 | Buy/Sell | $69.00 | 42.59% | 0 | $2.09B |
SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$29.10 | Buy/Sell | $41.00 | 40.89% | 0 | $1.72B |
AIP | Adcock Ingram Holdings | Hold |
16
|
R55.01 | Buy/Sell | R55.97 | 1.80% | 1 | R8.41B |
CHRS | Coherus BioSciences | Outperform |
6
|
$2.12 | Buy/Sell | $10.86 | 277.36% | 3 | $255.37M |
ASRT | Assertio Holdings | Buy |
8
|
$1.07 | Buy/Sell | $3.50 | 180.37% | 2 | $100.36M |